Curis
CRIS
#11081
Rank
S$0.86 M
Marketcap
S$0.44
Share price
-17.89%
Change (1 day)
-78.85%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$30.45

According to Curis's latest financial reports the company's current EPS (TTM) is S-$30.51. In 2025 the company made an earnings per share (EPS) of S-$30.51 an increase over its 2024 EPS that were of S-$180.22.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$30.45-0.18%
2025S-$30.51-83.07%
2024S-$180.22-22.15%
2023S-$231.49-26.17%
2022S-$313.5322.3%
2021S-$256.36-25.37%
2020S-$343.52-30.93%
2019S-$497.34-2.02%
2018S-$507.59
2016S-$1,154-10%
2015S-$1,282138.1%
2014S-$538.3640%
2013S-$384.54-25%
2012S-$512.7266.67%
2011S-$307.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.68-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.56-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.01-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.46-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$6.46-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA